Anti-obesity effect and mechanism of chitooligosaccharides were revealed based on lipidomics in diet-induced obese mice

M Zhou, J Huang, J Zhou, C Zhi, Y Bai, Q Che, H Cao… - Molecules, 2023 - mdpi.com
Chitooligosaccharide (COS) is a natural product from the ocean, and while many studies
have reported its important role in metabolic diseases, no study has systematically …

Effect of chitooligosaccharides with a specific degree of polymerization on multiple targets in T2DM mice

J You, M Zhao, S Chen, L Jiang, S Gao, H Yin… - Bioresources and …, 2022 - Springer
Chitooligosaccharides (COS) are found naturally in the ocean and present a variety of
physiological activities, of which hypoglycemic action has attracted considerable research …

Chitosan oligosaccharides improve glucolipid metabolism disorder in liver by suppression of obesity-related inflammation and restoration of peroxisome proliferator …

Y Bai, J Zheng, X Yuan, S Jiao, C Feng, Y Du, H Liu… - Marine Drugs, 2018 - mdpi.com
Chitosan oligosaccharides (COS) display various biological activities. In this study, we
aimed to explore the preventive effects of COS on glucolipid metabolism disorder using …

Chitooligosaccharide ameliorates diet-induced obesity in mice and affects adipose gene expression involved in adipogenesis and inflammation

EH Choi, HP Yang, HS Chun - Nutrition Research, 2012 - Elsevier
Chitooligosaccharide (CO) has been reported to have potential antiobestic effects in a few
studies, but the antiobesity properties of CO and its related mechanisms in models of dietary …

Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in …

N He, S Wang, Z Lv, W Zhao, S Li - Food & function, 2020 - pubs.rsc.org
In this study, the two enzymatic low molecular weight chitosan oligosaccharides (LMW-
COSs), LMW-COS-H and LMW-COS-L, were prepared with average MWs of 879.6 Da and …

Chitosan Oligosaccharide Ameliorates Metabolic Syndrome Induced by Overnutrition via Altering Intestinal Microbiota

Y Wang, S Liu, D Tang, R Dong, Q Feng - Frontiers in Nutrition, 2021 - frontiersin.org
Chitosan oligosaccharides (COS) play a prebiotic role in many ways, whereas its function on
microbiota is not fully understood. In this study, the effects of COS on metabolic syndrome …

Chitosan oligosaccharide ameliorates nonalcoholic fatty liver disease (NAFLD) in diet-induced obese mice

M Qian, Q Lyu, Y Liu, H Hu, S Wang, C Pan, X Duan… - Marine drugs, 2019 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is a global epidemic, and there is no standard and
efficient therapy for it. Chitosan oligosaccharide (COS) is widely known to have various …

[HTML][HTML] Cholesterol-lowering effects and potential mechanisms of chitooligosaccharide capsules in hyperlipidemic rats

Y Jiang, C Fu, G Liu, J Guo, Z Su - Food & Nutrition Research, 2018 - ncbi.nlm.nih.gov
Background Chitooligosaccharide (COS) has shown potential antihyperlipidemic activity in a
few studies as a functional food. Method We investigated the cholesterol-lowering effect and …

Anti-obesity effect of chitosan oligosaccharide capsules (COSCs) in obese rats by ameliorating leptin resistance and adipogenesis

H Pan, C Fu, L Huang, Y Jiang, X Deng, J Guo, Z Su - Marine drugs, 2018 - mdpi.com
Obesity is a global disease that causes many metabolic disorders. However, effective agents
for the prevention or treatment of obesity remain limited. This study investigated the anti …

[HTML][HTML] Xylan-oligosaccharides ameliorate high fat diet induced obesity and glucose intolerance and modulate plasma lipid profile and gut microbiota in mice

C Zhang, AAA Abdo, B Kaddour, Q Wu, L Xin… - Journal of Functional …, 2020 - Elsevier
In recent years, xylan-oligosaccharides (XOS) have attracted much interest as an alternative
sweetener for formulating an anti-obesity diet. The present study combining the plasma …